MEDICINOVA INC — Form SCHEDULE 13D/A
Filed September 29, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
Two entities—3D Investment Partners Pte. Ltd. and 3D Opportunity Master Fund—signed a joint filing agreement dated September 29, 2026, to file a Schedule 13D amendment together regarding MediciNova common stock. The filing provides the joint agreement but no disclosure of shareholding percentage, share count, or acquisition details. This is a procedural coordination document; substantive holdings or intent are not specified in this exhibit.
Why this rating
Procedural filing coordination document with no disclosed position size, dollar amount, or strategic intent. Routine administrative filing relative to company scale.
See more from September 29, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.